The Global Eubiotics Market was valued at ~US$ 3 billion in 2017. It is estimated to be ~US$ 5 billion by 2022 and is expected to reach a market size of ~US$ 8 billion by 2028 growing at a CAGR of ~8% during the forecast period (2022-2028). Due to the rise in demand for animal protein, the rise in demand for produced feed, and the restriction on antibiotics, the market for animal Eubiotics will experience significant expansion.
For more information, Request a free Sample Report
Key Growth Drivers
Key Trends by Market Segment
By Product: Probiotics segment held the largest market share in 2021, This is ascribed to growing consumer awareness of the use of probiotics in animal feed, continued R&D efforts to create effective solutions, and extensive product portfolios offered by key industry players.
By Form: Drysegment held the largest market share in 2021, this significant percentage is explained by its benefits, such as improved defense against light and moisture exposure.
For more information, Request a free Sample Report
By Function: The nutrition and gut health segment held the largest market share in 2021, The causes can be linked to the effectiveness of Eubiotics in improving gut health and the creation of effective eubiotic carrier mediums for improved distribution in the intestinal system.
By Livestock: The poultry segment held the largest market share in 2021, due to the rise in chicken consumption, the improvement of poultry bird health, and the provision of protein.
By Geography: Europeheld the largest market share in 2021, because of the region's strict rules and regulations that forbid the use of antibiotics, the existence of major market players, and awareness of the use of Eubiotics and their advantages.
For more information, Request a free Sample Report
Competitive Landscape
The global Eubiotics market is highly competitive with ~150 players which include globally diversified players, regional players, and country-niche players with their niche in the Eubiotics market. County-niche players constitute ~45% of the competitors, while the regional players are the second largest by type. Some of the major players in the market include and among others DSM, Novus International, Inc., Lallemand, Inc., Behn Meyer, Lesaffre Group, Kemin Industries, Inc., Novozymes, Chr. Hansen Holding A/S, BASF SE, and others.
Recent Developments Related to Major Players
Conclusion
The global Eubiotics market is forecasted to continue the growth that is witnessed since 2017, Positive legislative scenarios that forbid the use of antibiotics and rising meat consumption around the world are expected to fuel demand for the product. The market is highly competitive, with firms who have been there for a while taking the majority of the market. Though the market is highly competitive with ~150 players, few global players control the dominant market share and regional players also hold a significant market share.
Note: This is an On-Demand/Planned report, so the figures quoted here for a market size estimate, forecast, growth, segment share, and competitive landscape are based on initial findings and might vary slightly in the actual report. Also, any required customizations can be covered to the best feasible extent for Pre-booking clients, and the report delivered within a maximum of two working weeks.
Ken Research has recently published report titled, “Global Eubiotics Market Size, Segments, Outlook, and Revenue Forecast 2022-2028” The Eubiotics market is segmented by product, form, function, and livestock. In addition, the report also covers market size and forecasts for the four region’s Eubiotics markets. The revenue used to size and forecast the market for each segment is US$ billion.
Market Taxonomy
By Product |
|
By Form |
|
By Function |
|
By Livestock |
|
By Geography |
|
Leading Companies |
|
For more information on the research report, refer to below link: